Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1].
[1]. Oh Y, et al. Part II: Prognosis and management. J Am Acad Dermatol. 2021 Nov;85(5):1093-1106.
Brentuximab 是靶向 CD30 的嵌合抗体。Brentuximab 可用于新兴靶向疗法的研究。
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥3,150.00 | 现货 | 1 | |
| 5mg | ¥8,820.00 | 现货 | 1 |
















Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1].
[1]. Oh Y, et al. Part II: Prognosis and management. J Am Acad Dermatol. 2021 Nov;85(5):1093-1106.